Patents/Assignees

Gritstone Bio, Inc.

5 patents in portfolio

US12109257utility2024
Alphavirus Neoantigen Vectors
0 cites
US12098383utility2024
Modified Adenoviruses
0 cites
US11885815utility2024
Reducing Junction Epitope Presentation for Neoantigens
0 cites
US11771747utility2023
Multiepitope Vaccine Cassettes
0 cites
US11591619utility2023
Modified Adenoviruses
0 cites